The European cosmetics legislation foresees a review in 2011 and possible postponement of the 2013 marketing ban to enforce the testing ban for systemic and repeated-dose animal tests. For this purpose, a 119-page report commissioned by the European Commission was published recently. Here, a group of 17 independent experts from the US, Europe, and Japan was brought together to evaluate the report. The expert panel strongly endorsed the report and its conclusions. A number of important options not considered were identified; these do not, however, affect the overall conclusions regarding the current lack of availability of a full replacement, especially for the areas of repeated dose toxicity, carcinogenicity testing, and reproductive toxicity, though a roadmap for change is emerging. However, some of these options may provide adequate data for replacement of some animal studies in the near future pending validation. Various recommendations expand the original report. The reviewers agree with the report that there is greater promise in the short term for the areas of sensitization and toxicokinetics. Additional opportunities lie in more global collaborations and the inclusion of other industry sectors.

An expert consortium review of the EC-commissioned report alternative (Non-Animal) methods for cosmetics testing: current status and future prospects - 2010 / T. Hartung, B.J. Blaauboer, S. Bosgra, E. Carney, J. Coenen, R.B. Conolly, E. Corsini, S. Green, E.M. Faustman, A. Gaspari, M. Hayashi, A. Wallace Hayes, J.G. Hengstler, L.E. Knudsen, T.B. Knudsen, J.M. McKim, W. Pfaller, E.L. Roggen. - In: ALTERNATIVES TO ANIMAL EXPERIMENTATION. - ISSN 1868-596X. - 28:3(2011), pp. 183-209.

An expert consortium review of the EC-commissioned report alternative (Non-Animal) methods for cosmetics testing: current status and future prospects - 2010

E. Corsini;
2011

Abstract

The European cosmetics legislation foresees a review in 2011 and possible postponement of the 2013 marketing ban to enforce the testing ban for systemic and repeated-dose animal tests. For this purpose, a 119-page report commissioned by the European Commission was published recently. Here, a group of 17 independent experts from the US, Europe, and Japan was brought together to evaluate the report. The expert panel strongly endorsed the report and its conclusions. A number of important options not considered were identified; these do not, however, affect the overall conclusions regarding the current lack of availability of a full replacement, especially for the areas of repeated dose toxicity, carcinogenicity testing, and reproductive toxicity, though a roadmap for change is emerging. However, some of these options may provide adequate data for replacement of some animal studies in the near future pending validation. Various recommendations expand the original report. The reviewers agree with the report that there is greater promise in the short term for the areas of sensitization and toxicokinetics. Additional opportunities lie in more global collaborations and the inclusion of other industry sectors.
3Rs; Alternatives to animal testing; Novel approaches; Product safety; Toxicology
Settore BIO/14 - Farmacologia
2011
http://www.altex.ch/en/index.html?id=50&iid=127&aid=2
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/208076
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 48
  • ???jsp.display-item.citation.isi??? 45
social impact